RAD 140
SARMs

RAD 140

Product Details Dragon Pharma
Active Substance RAD 140 Testolone
Strength 10 mg per tablet
Package 100 tablets Manufacturer sachet
Form Oral tablets
Estimated Half-Life Approximately 20–24 hours
Water Retention Low
Aromatization No
Primary Concerns Lipids, suppression & liver

Potential effects and adverse reactions vary between individuals.

Out of stock

Dragon Pharma RAD 140 10 mg – Selective Androgen Receptor Modulator for Research

βœ” Selective androgen receptor modulator βœ” Oral administration βœ” Studied for lean tissue preservation βœ” USA domestic shipping available

Dragon Pharma RAD 140 10 mg is a selective androgen receptor modulator (SARM) also known as Testolone. This investigational compound is designed to bind selectively to androgen receptors in muscle and bone tissue, making it a subject of research for its potential to promote lean muscle growth, strength enhancement, and bone health with reduced androgenic side effects compared to traditional anabolic compounds.

Each package contains 100 tablets at 10 mg per tablet, supplied in a manufacturer sachet. RAD 140 has been investigated in preclinical research for its tissue-selective anabolic properties and its potential applications in muscle-wasting conditions and performance research. For related research compounds, explore our SARMs category and specifically LGD 4033 for comparative SARM research applications.

What Makes RAD 140 Valuable in Research?

RAD 140 is one of the most potent and tissue-selective SARMs developed to date. Its unique structure allows for targeted androgen receptor activation in muscle and bone while minimizing activity in other tissues such as the prostate and seminal vesicles. This selectivity makes it a valuable compound for investigating the therapeutic potential of tissue-specific androgen receptor modulation.

Researchers value RAD 140 for its favorable pharmacokinetic profile, including oral bioavailability and a relatively long half-life. Its potent anabolic effects in preclinical models have made it a focus of research into muscle preservation, strength enhancement, and bone health. For investigators exploring other performance-related compounds, Anavar 10 offers complementary research avenues in anabolic and strength studies.

Current scientific literature on SARMs, including RAD 140, can be accessed through the PubMed database, where researchers can review peer-reviewed studies on their biological activity and experimental applications.

Key Research Applications for Dragon Pharma RAD 140

  • βœ” Investigation of selective androgen receptor modulation
  • βœ” Evaluation of lean muscle mass preservation and growth
  • βœ” Research on strength enhancement and physical performance
  • βœ” Studies of bone health and anabolic signaling
  • βœ” Preclinical models of muscle-wasting conditions
For Research Purposes Only

RAD 140 10 mg is intended for research use only and is not approved for human consumption. Proper handling, dosing, and experimental protocols are essential for reliable results. For studies on metabolic enhancement, MK 2866 provides additional research avenues in selective androgen receptor modulation.

Product Details

Active Substance
RAD 140
Alternative Name
Testolone
Formulation
Oral tablets
Strength
10 mg per tablet
Package
100 tablets
Half-Life
Approximately 20–24 hours
Mechanism
Selective androgen receptor modulator
Presentation
Manufacturer sachet
Brand
Dragon Pharma
Availability
USA Domestic & International

Dosage & Usage Guidelines

For research and laboratory use only. Dragon Pharma RAD 140 10 mg is a selective androgen receptor modulator. Proper handling, dosing, and experimental design are essential for obtaining reliable data.

Administration Profile

  • βœ” Oral administration
  • βœ” Convenient once-daily dosing
  • βœ” Rapid absorption

Due to its favorable oral bioavailability and long half-life, RAD 140 is typically administered once daily in research settings. Consistent dosing schedules help maintain stable compound levels for reliable experimental results.

Typical Research Parameters

In research settings, RAD 140 dosing protocols vary widely depending on the experimental design, animal model, and specific research objectives.

  • βœ” Commonly used in muscle growth and preservation studies
  • βœ” Often combined with histological and molecular analysis
  • βœ” Used to investigate androgen receptor signaling pathways
  • βœ” Research models include muscle-wasting and performance paradigms

Factors to Consider in Research Protocols

  • Potent SARM requiring careful dose titration
  • Hormonal suppression considerations in longer studies
  • Lipid profile monitoring recommended
  • Storage conditions significantly impact compound stability

Research note: RAD 140 is one of the most potent tissue-selective SARMs developed to date. Its ability to activate androgen receptors in muscle and bone while minimizing activity in other tissues makes it a valuable tool for investigating tissue-specific androgen receptor modulation and potential therapeutic applications in muscle-wasting conditions.

Shipping & Product Authenticity

USA Domestic
4–5 business days
International
13–15 business days
Order Processing
24–48 business hours
Tracking
Tracking number provided
Direct Supply & Discreet Delivery

This product is supplied through the official Dragon Pharma distribution chain and shipped in original manufacturer packaging. The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.

What to Expect

  • βœ” Orders are processed after payment confirmation
  • βœ” USA Domestic shipping is typically faster when local stock is selected
  • βœ” International orders include tracking, though update frequency may vary by destination
  • βœ” Multiple warehouses may result in separate shipments when applicable
Authenticity support: official Dragon Pharma presentation, batch-linked lab proof, and original packaging help reinforce product legitimacy and buyer confidence.
Verified Supply

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Store tablets at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. Keep the sachet sealed until use to maintain product integrity.

Keep out of reach of children. Follow proper handling and disposal practices during research use.

Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.

Frequently Asked Questions

What is Dragon Pharma RAD 140 10 mg used for?

RAD 140 is used in research to investigate selective androgen receptor modulation, lean muscle growth, strength enhancement, and bone health. It is a potent SARM also known as Testolone.

How does RAD 140 work?

RAD 140 selectively binds to androgen receptors in muscle and bone tissue, promoting anabolic signaling while minimizing activity in other tissues such as the prostate. This tissue selectivity makes it valuable for investigating targeted androgen receptor modulation.

What is the half-life of RAD 140?

RAD 140 has an estimated half-life of approximately 20–24 hours, allowing for once-daily oral administration in research settings.

What is the typical dosage for RAD 140 in research?

Research dosages vary depending on the experimental design. In preclinical studies, doses have ranged from 0.1 to 1 mg/kg in animal models. Proper dose titration and monitoring are essential.

Is Dragon Pharma RAD 140 10 mg lab-tested?

Third-party laboratory testing for RAD 140 10 mg is currently pending. Batch-specific COA data will be published once analytical testing is completed and verified.

No reviews found

Please log in to write RAD 140 review.

Related Offers
Lab Tested
Domestic & International
S 23
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Mastorin Selective androgen receptor modulator (SARM)
Strength 10 mg/tablet
Package 100 tablets 1,000 mg total labeled content
Form Oral tablets
Estimated Half-Life Approximately 12 hours Estimate based primarily on preclinical data
Water Retention Not established Limited human safety data
Aromatization No Not an aromatizable steroid
Primary Concerns Hormonal and reproductive suppression Investigational compound with limited human safety data
Latest laboratory result 12.43 mg/tablet April 18, 2025 · 124.3% of label claim · Batch HDS23923 View
$60.00
Lab Tested
Shipped USA Domestic
MK 677
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Ibutamoren (MK-677) Growth hormone secretagogue / ghrelin receptor agonist
Strength 25 mg/tablet
Package 100 tablets 2,500 mg total labeled content
Form Oral tablets
Estimated Half-Life Approximately 24 hours
Water Retention Possible Mild edema has been reported in clinical studies
Aromatization Not applicable Not an androgenic steroid
Primary Concerns Blood glucose, insulin sensitivity and fluid retention Investigational compound with limited long-term safety data
Latest laboratory result 24.22 mg/tablet April 18, 2025 · 96.88% of label claim · Batch HDIBT923 View
$160.00
Lab Tested
Domestic & International
LGD 4033
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Ligandrol (LGD-4033) Selective androgen receptor modulator (SARM)
Strength 15 mg/tablet
Package 100 tablets 1,500 mg total labeled content
Form Oral tablets
Estimated Half-Life Approximately 24–36 hours
Water Retention Not typically associated
Aromatization No Does not convert to estrogen through aromatase
Primary Concerns Hormonal suppression, lipid changes and liver injury Not approved for human therapeutic use
Latest laboratory result 15.66 mg/tablet April 18, 2025 · 104.4% of label claim · Batch HDLGD23 View
$95.00
Lab Tested
Domestic & International
MK 2866
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Ostarine (MK-2866) Selective androgen receptor modulator (SARM)
Strength 25 mg/tablet
Package 100 tablets 2,500 mg total labeled content
Form Oral tablets
Estimated Half-Life Approximately 24 hours
Water Retention Not typically associated
Aromatization No Does not convert to estrogen through aromatase
Primary Concerns Hormonal suppression, lipid changes and liver injury Not approved for human therapeutic use
Latest laboratory result 23.89 mg/tablet April 18, 2025 · 95.56% of label claim · Batch HD0NE923 View
$90.00
Lab Tested
Domestic & International
YK 11
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance YK-11 Steroidal selective androgen receptor modulator (SARM)
Strength 10 mg/tablet
Package 100 tablets 1,000 mg total labeled content
Form Oral tablets
Estimated Half-Life Not established in humans Limited pharmacokinetic data
Water Retention Not established Limited human safety data
Aromatization Not established Human endocrine effects are insufficiently characterized
Primary Concerns Hormonal and liver effects Experimental compound with limited human safety data
Latest laboratory result 9.29 mg/tablet April 18, 2025 · 92.9% of label claim · Batch HDYK923 View
$145.00
Lab Tested
Domestic & International
GW501516
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Cardarine (GW501516) PPARδ receptor agonist
Strength 20 mg/tablet
Package 100 tablets 2,000 mg total labeled content
Form Oral tablets
Estimated Half-Life Approximately 16–24 hours
Water Retention Not typically associated
Aromatization No Not an androgenic or estrogenic compound
Primary Concerns Long-term safety and carcinogenicity concerns Not approved for human therapeutic use
Latest laboratory result 21.70 mg/tablet June 18, 2024 · 108.5% of label claim · Batch HDGW23 View
$90.00
Lab Tested
Domestic & International
Halotestin 10 mg
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Fluoxymesterone Oral anabolic-androgenic steroid
Strength 10 mg/tablet
Package 100 tablets 1,000 mg total labeled content
Form Oral tablets
Estimated Half-Life Approximately 9 hours
Water Retention Low Does not aromatize to estrogen
Aromatization No Non-aromatizing androgen
Primary Concerns Liver strain and androgenic effects 17α-alkylated oral compound
Latest laboratory result 9.88 mg/tablet August 7, 2024 · 98.8% of label claim · Batch HFL1022D View
$154.00
Domestic & International
Buy 3 and get 1 for FREE
Oral Tren
Dragon Pharma, Europe
Product Details Dragon Pharma
Active Substance Methyltrienolone Oral anabolic-androgenic steroid
Strength 250 mcg/tablet
Package 100 tablets 25 mg total labeled content
Form Oral tablets
Estimated Half-Life Approximately 6 hours
Water Retention Possible Progestogenic activity may contribute to related effects
Aromatization No Does not convert to estrogen through aromatase
Primary Concerns Severe liver toxicity and androgenic effects 17α-alkylated oral compound
$44.00
Buy 3 and get 1 for FREE
Buy 5+ for $40.92 and save $15.40

Add to Cart - Product(s)

Close Button
Empty

Total Cost: